NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 689626 | Null | 0.043472147060915 | 0.2945332 |
NSC 6926 | Null | 0.043472147060915 | 0.42135389 |
NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0434721470609156 | 0.12718037 |
NSC 709974 | Null | 0.0434721470609156 | 0.22193738 |
NSC 715407 | Null | 0.0434721470609156 | 0.3440627 |
NSC 717468 | Null | 0.0434721470609156 | 0.12168381 |
NSC 718630 | Null | 0.0434721470609156 | 0.36911063 |
NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0434721470609156 | 0.22870789 |
NSC 720497 | Null | 0.0434721470609156 | -0.1408136 |
NSC 726217 | Combretastatin A4-analogue | 0.0434721470609156 | 0.3028917 |